Skip to main content

Mobilicom Launches SkyHopper Tactical, Advancing Tactical Drone and Autonomous Operations Capabilities

New Wearable SDR Broadens Mobilicom’s SkyHopper Product Portfolio Based on Evolving U.S. Department of War Operational Requirements Palo Alto, California, May 11, 2026 (GLOBE NEWSWIRE) — Mobilicom Limited (Nasdaq: MOB, MOBBW) (“Mobilicom” or the “Company”), a provider of cybersecurity and robust solutions for drones and robotics, today announced the launch of SkyHopper Tactical, a new wearable software-defined radio (“SDR”) designed to expand the Company’s tactical edge communications portfolio supporting autonomous systems. The SkyHopper Tactical launch follows Mobilicom’s March 2026 introduction of SkyHopper MultiBand, growing the Company’s family of cybersecure SDR solutions for forces operating in contested electronic warfare and complex terrain environments. “SkyHopper Tactical further expands Mobilicom’s cybersecure autonomous...

Continue reading

Amex Exploration Announces Oversubscribed C$43.5 Million LIFE Offering and Additional Concurrent Private Placement of Up to C$31 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTREAL, May 11, 2026 (GLOBE NEWSWIRE) — Amex Exploration Inc. (TSXV: AMX) (FSE: MX0) (OTCQX: AMXEF) (“Amex” or the “Company”) is pleased to announce that as a result of excess demand, it has amended its previously announced agreement with National Bank Financial Inc. and MDCP Securities Limited (together, the “Co-Lead Agents”), as joint bookrunners and co-lead agents, on behalf of a syndicate of agents (collectively, the “Agents”), in connection with a “best efforts” private placement offering under the LIFE Exemption (as defined herein) for up to 9,661,000 common shares of the Company (the “Common Shares“) at a price of $4.50 per Common Share (the “Offering Price”) for aggregate gross proceeds of up to $43,474,500 (the “LIFE Offering“). The...

Continue reading

Verizon announces tender offers and consent solicitations for 20 series of Verizon and certain of its subsidiaries’ notes

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) — Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the commencement of 20 separate offers, for its own account and on behalf of certain of its wholly-owned subsidiaries, to purchase for cash (i) any and all of the debt securities listed in Table 1 below (the “Any and All Notes” and such offers, the “Any and All Tender Offers”) and (ii) up to $1.25 billion aggregate purchase price of the outstanding series of debt securities listed in Table 2 below (the “Waterfall Notes” and, together with the Any and All Notes, the “Notes” and such offers, the “Waterfall Tender Offers” and, together with the Any and All Tender Offers, the “Tender Offers”), on the terms and subject to the conditions set forth in the Offer to Purchase and Consent Solicitation Statement dated May 11,...

Continue reading

Verizon announces private exchange offers and consent solicitations for 11 series of notes open to certain investors

NEW YORK, May 11, 2026 (GLOBE NEWSWIRE) — Verizon Communications Inc. (“Verizon”) (NYSE, Nasdaq: VZ) today announced the commencement of offers to exchange (the “Exchange Offers”), on behalf of certain of its wholly-owned subsidiaries, any and all of the outstanding series of debt securities listed below (the “Old Notes”) for specified series of newly issued notes of Verizon (collectively, the “New Notes”) on the terms and subject to the conditions set forth in the Exchange Offer and Consent Solicitation Statement dated May 11, 2026 (the “Exchange Offer and Consent Solicitation Statement” and, together with the accompanying letter of transmittal (the “Letter of Transmittal”) and eligibility letter, the “Exchange Offer Documents”). Concurrently with the Exchange Offers, Verizon, on behalf of such subsidiaries, is soliciting consents...

Continue reading

Apyx Medical Corporation Receives Expanded FDA 510(k) Clearance Adding Power Liposuction Capability to AYON Body Contouring System™

Addition of the power liposuction capability as a second advanced liposuction modality is expected to drive even greater market demand for AYON CLEARWATER Fla., May 11, 2026 (GLOBE NEWSWIRE) — Apyx Medical Corporation (Nasdaq: APYX) (the “Company” or “Apyx Medical”), the leader in surgical aesthetics products marketed and sold as Renuvion® and the AYON Body Contouring System™ (AYON), today announced it received expanded 510(k) clearance from the U.S. Food and Drug Administration (the “FDA”) for the AYON Body Contouring System (“AYON”) to include power liposuction, an advanced form of liposuction that uses a reciprocating cannula to enhance efficiency of fat removal to reduce a surgeon’s effort and operating room time. “With the addition of our advanced power liposuction function, we believe AYON is the gold-standard system...

Continue reading

FTI Consulting Appoints Financial Services Transactions Expert Emanuele Grasso to Lead in Italy

MILAN, May 11, 2026 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Emanuele Grasso as a Senior Managing Director and Leader of the firm’s Corporate Finance segment in Italy. Based in Milan, Mr. Grasso returns to Italy after nearly a decade in New York, bringing more than 30 years of experience advising private equity firms, insurers, asset managers, payment services providers and other global financial services institutions on complex corporate transactions. During his time in New York, he advised leading international clients on several high-profile cross-border deals, further strengthening his global perspective. His expertise is particularly focused on financial due diligence, M&A and all aspects of special purpose acquisition company transactions. Mr. Grasso has worked on deals in...

Continue reading

TRIO PETROLEUM CORP ANNOUNCES STRATEGIC EXPANSION INITIATIVE FOLLOWING SUCCESSFUL CAPITAL RAISE AND ENCOURAGES STOCKHOLDER SUPPORT AT MAY 21ST ANNUAL MEETING

Malibu, California, May 11, 2026 (GLOBE NEWSWIRE) — Trio Petroleum Corp (“Trio” or the “Company”) today announced that it has strengthened its financial position through recent capital raises totaling approximately $24 million via its At-The-Market (“ATM”) equity program. With a substantially improved balance sheet and capital available for deployment, Trio has entered what management believes is a transformational phase focused on growth through strategic acquisitions. The Company through its Canadian subsidiary has assembled a multidisciplinary team of seasoned upstream oil and gas specialists, combining top-tier land, engineering, and operational expertise to fast track identifying, reviewing, and engaging potential oil and gas acquisition opportunities. The team has been participating in discussions on select projects and plans...

Continue reading

Team, Inc. Announces Timing of First Quarter 2026 Earnings Release and Conference Call

SUGAR LAND, Texas, May 11, 2026 (GLOBE NEWSWIRE) — Team, Inc. (NYSE: TISI) (“TEAM” or the “Company”), a global leading provider of specialty industrial services offering customers access to a full suite of conventional, specialized, and proprietary mechanical, heat-treating, and inspection services, today announced that it will issue its first quarter 2026 earnings release on Wednesday, May 13, 2026 after the close of trading on the New York Stock Exchange. TEAM will host a conference call to discuss its financial and operational results on Thursday morning, May 14, 2026 at 10:00 a.m. Central Time (11:00 a.m. Eastern Time). Interested parties in the United States may participate toll-free by dialing (877) 270-2148. Interested parties internationally may dial (412) 902-6510. Participants should ask to join “TEAM, Inc. First Quarter...

Continue reading

Assembly Biosciences to Present at the BofA Securities 2026 Global Health Care Conference

SOUTH SAN FRANCISCO, Calif., May 11, 2026 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced that Anuj Gaggar, MD, PhD, chief medical officer, will present during the Bank of America Securities 2026 Global Health Care Conference at 4:35 p.m. Pacific Time on May 13, 2026. A live webcast will be available on the Events and Presentations section of Assembly Bio’s website, and a replay will be accessible following the event. To register for the live webcast and replay, please visit: https://investor.assemblybio.com/events-presentations. About Assembly Biosciences Assembly Biosciences is a biotechnology company dedicated to the development of innovative small-molecule therapeutics designed to change the path of serious...

Continue reading

CalEthos, Inc. and its subsidiary, TerraVolt Infrastructure, Inc., sign a Natural Gas Supply Agreement for TerraVolt’s planned AI Data Center Infrastructure Development

Tustin, CA, May 11, 2026 (GLOBE NEWSWIRE) — CalEthos, Inc. (OTCQB:GEDC), and its subsidiary TerraVolt Infrastructure, Inc. (“TerraVolt” or, collectively with CalEthos, Inc., the “Company”), today announced the execution of an agreement with a top-tier natural gas marketing company for the FIRM supply to the Company of natural gas for TerraVolt’s planned behind-the-meter onsite power plant. Under the terms of the agreement, the natural gas supplier will provide the Company with 55,000 MMBTU per day of natural gas. This supply of contracted natural gas ensures the Company will be able to provide a stable, reliable energy source for TerraVolt’s master-planned data center campus development, which is to be located in Southeast Idaho on the Northwest Natural Gas Pipeline. Joel Stone, Chairman and CEO of the Company, stated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.